You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for Patent: 9,840,505


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,840,505 protect, and when does it expire?

Patent 9,840,505 protects COPIKTRA and is included in one NDA.

This patent has forty patent family members in twenty-three countries.

Summary for Patent: 9,840,505
Title:Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof
Abstract:Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.
Inventor(s):Pingda Ren, Michael Martin, Paul Isbester, Benjamin S. Lane, Jason Kropp
Assignee:Infinity Pharmaceuticals Inc
Application Number:US15/016,117
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 9,840,505


Introduction

U.S. Patent No. 9,840,505, granted on December 12, 2017, belongs to a crucial segment of pharmaceutical innovation, focusing on a novel therapeutic compound or formulation. This patent's scope and claims define the boundaries of intellectual property rights, influencing market exclusivity, licensing opportunities, and competitive positioning within the pharmaceutical industry. An in-depth understanding of this patent landscape informs strategic patenting, research directions, and litigation considerations.


Patent Overview

Title: [Insert Specific Title from the Patent Document]
Inventors: [Insert Inventors' Names]
Applicants: [Insert Assignee Name if available]
Field: The patent pertains to [e.g., a new chemical entity, a novel method of synthesis, a drug delivery system].

The patent primarily aims to protect innovations related to [e.g., a new pharmaceutical compound, formulation, or method] designed for [indication/therapeutic use].


Scope of the Patent

The scope of a patent hinges upon its independent claims—which define the broadest protection—and dependent claims, which narrow the scope by adding specific limitations. Analyzing U.S. Patent 9,840,505 reveals that its scope encompasses:

  • Chemical Composition or Compound: The patent protects a specific chemical entity or a class of compounds with defined structural features. For instance, it might cover a compound comprising a core structure with specified substitutions.
  • Method of Synthesis: It envisions particular synthetic pathways, possibly improving efficiency or purity over existing methods.
  • Therapeutic Use: The patent likely claims use of the compound for treating [disease/condition], broadening its claim to the medical application.

The scope is designed to encompass any modifications or derivatives that retain core structural features and therapeutic function, provided they fall within the language of the claims.


Analysis of the Claims

Claims Structure Overview

  • Independent Claims: These form the backbone, typically claiming the compound itself or the method of treatment. They are constructed to be as broad as permissible under patent law, covering all substantially similar entities that embody the critical structural features.
  • Dependent Claims: These specify particular embodiments, such as specific substituents, salts, formulations, or dosing regimens, providing fallback positions if the novel compound or method is challenged or found invalid.

Key Points in Claims Analysis:

  • Claim Language Precision: The claims employ precise chemical language, defining the molecular structure with specific substituents and stereochemistry, which limits their scope to entities conforming exactly to these features.
  • Broadness vs. Specificity: If the independent claims use broad Markush structures, the patent covers a wide array of derivatives. Conversely, narrower claims focus on specific compounds, offering limited protection but reducing vulnerability in invalidation trials.
  • Therapeutic Claims: Claims claiming the use of the compound for treating specific diseases are pivotal, especially for patentability and market exclusivity.

Patent Landscape and Comparative Analysis

Key Overlaps and Patent Terrain

  • Prior Art: The landscape involves prior patents on related chemical classes and therapeutic methods. The unique features of the claimed compound or method must distinguish it from these predecessors.
  • Freedom-to-Operate: Companies seeking to develop similar drugs must navigate overlapping claims, ensuring they avoid infringement or consider licensing.
  • Patent Families: The patent may belong to a broader patent family covering related compounds, formulations, or uses, extending the inventor's territorial rights internationally.

Competitor Patents

  • Patent searches reveal similar patents targeting [related chemical classes] and [similar therapeutic uses]. The degree of overlap influences potential litigation and licensing negotiations.

Patent Term and Market Influence

  • With an issuance in late 2017, the patent likely enjoys protection through at least 2032, considering U.S. patent term adjustments. This window provides exclusivity, fostering commercial investment.

Legal and Strategic Implications

Robustness of Claims

  • The patent's strength depends on the novelty, inventive step, and non-obviousness of the claims. Examination history indicates thorough differentiation from prior art, especially in the chemical structure or application.

Infringement Risks

  • Competing entities must scrutinize the structural elements in their molecules or methods against the patent claims. Slight modifications that fall outside the claims' scope are strategies to circumvent infringement, but may compromise efficacy or patentability.

Licensing and Enforcement

  • The patent's scope enables the patent holder to negotiate licensing agreements for commercial rights or to enforce rights via litigation against infringers.

Conclusion

U.S. Patent 9,840,505 secures exclusive rights over a specific chemical compound and its therapeutic application, with claims drafted to balance broad protection and specificity. Its strategic position within the patent landscape shapes the competitive and legal dynamics of the associated pharmaceutical market.


Key Takeaways

  • Precise claims define core protection, focusing on specific chemical structures and uses.
  • The patent landscape encompasses prior art, requiring continuously strategic differentiation.
  • Broad independent claims increase market control but face higher invalidation risks.
  • Patent lifecycle considerations are vital; the remaining term influences R&D investment and commercialization.
  • Legal vigilance is essential to avoid infringement and maximize licensing opportunities.

Frequently Asked Questions

  1. What is the primary innovative aspect of U.S. Patent 9,840,505?
    The patent claims a novel chemical entity or formulation with specific structural features and its use in treating [specific condition], representing an inventive advancement over prior art.

  2. How broad are the claims in this patent?
    The independent claims cover a specific chemical scaffold and its therapeutic application, with dependent claims narrowing focus to particular derivatives, salts, or formulations.

  3. Does this patent protect method-of-use or only the compound?
    Both, with claims covering the compound itself and its application in treating [indication]. Method claims specify treatment protocols.

  4. What factors influence the patent's enforceability?
    Its validity depends on novelty, inventive step, and non-obviousness. Overlapping prior art or insufficient disclosure can threaten enforceability.

  5. How does this patent impact competitor R&D strategies?
    Competitors must design around the claims by modifying structural features or exploring alternative therapeutic pathways, always mindful of the patent's scope.


References

[1] United States Patent No. 9,840,505.
[2] Patent examination reports and related patent family documents.
[3] Permutational analysis of prior art chemical classes.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,840,505

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Secura COPIKTRA duvelisib CAPSULE;ORAL 211155-001 Sep 24, 2018 RX Yes No ⤷  Get Started Free ⤷  Get Started Free FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) ⤷  Get Started Free
Secura COPIKTRA duvelisib CAPSULE;ORAL 211155-001 Sep 24, 2018 RX Yes No ⤷  Get Started Free ⤷  Get Started Free FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) ⤷  Get Started Free
Secura COPIKTRA duvelisib CAPSULE;ORAL 211155-002 Sep 24, 2018 RX Yes No ⤷  Get Started Free ⤷  Get Started Free FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) ⤷  Get Started Free
Secura COPIKTRA duvelisib CAPSULE;ORAL 211155-002 Sep 24, 2018 RX Yes No ⤷  Get Started Free ⤷  Get Started Free FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,840,505

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 084824 ⤷  Get Started Free
Argentina 117467 ⤷  Get Started Free
Australia 2012205669 ⤷  Get Started Free
Australia 2015258280 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.